{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T17:24:13Z","timestamp":1788456253678,"version":"build-2803163510"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T00:00:00Z","timestamp":1743120000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["JR24\/00024"],"award-info":[{"award-number":["JR24\/00024"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thebreastonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Breast"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.breast.2025.104465","type":"journal-article","created":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T06:06:17Z","timestamp":1743919577000},"page":"104465","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Paclitaxel-related type I Kounis Syndrome in a very young patient with HER2-positive breast cancer and the role of genomics to disentangle a complex therapeutic scenario: a case report and narrative review"],"prefix":"10.1016","volume":"81","author":[{"given":"Javier","family":"Mu\u00f1oz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Nucera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuria","family":"Rubira Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaac","family":"Cebrecos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Oses","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergi","family":"Ganau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Sanfeliu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Jares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mercedes","family":"Mar\u00edn-Aguilera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Galv\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fara","family":"Bras\u00f3-Maristany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Mart\u00ednez-S\u00e1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enric","family":"Cascos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carme","family":"Font","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6561-1919","authenticated-orcid":false,"given":"Francesco","family":"Schettini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.breast.2025.104465_bib1","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.breast.2021.07.019","article-title":"Dissecting the biological heterogeneity of HER2-positive breast cancer","volume":"59","author":"Schettini","year":"2021","journal-title":"Breast"},{"key":"10.1016\/j.breast.2025.104465_bib2","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ctrv.2016.03.012","article-title":"Hormone Receptor\/Human Epidermal Growth Factor Receptor 2-positive breast cancer: where we are now and where we are going","volume":"46","author":"Schettini","year":"2016","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.breast.2025.104465_bib3","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.5858\/arpa.2018-0902-SA","article-title":"Human epidermal growth factor receptor 2 testing in breast cancer: American society of clinical oncology\/college of American pathologists clinical practice guideline focused update","volume":"142","author":"Wolff","year":"2018","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.breast.2025.104465_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103801","article-title":"Development and validation of the new HER2DX assay for predicting pathological response and survival outcome in early-stage HER2-positive breast cancer","volume":"75","author":"Prat","year":"2022","journal-title":"EBioMedicine"},{"key":"10.1016\/j.breast.2025.104465_bib5","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.1007\/s12094-023-03215-4","article-title":"SEOM-GEICAM-SOLTI clinical guidelines for early-stage breast cancer (2022)","volume":"25","author":"Ayala De La Pe\u00f1a","year":"2023","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.breast.2025.104465_bib6","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1515\/cclm-2016-0010","article-title":"Kounis syndrome: an update on epidemiology, pathogenesis, diagnosis and therapeutic management","volume":"54","author":"Kounis","year":"2016","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.breast.2025.104465_bib7","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jccase.2022.10.004","article-title":"Recurrent cardiac arrests caused by Kounis syndrome without typical allergic symptoms","volume":"27","author":"Masuda","year":"2023","journal-title":"Journal of Cardiology Cases"},{"key":"10.1016\/j.breast.2025.104465_bib8","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ejim.2015.12.004","article-title":"Kounis syndrome: a concise review with focus on management","volume":"30","author":"Fassio","year":"2016","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.breast.2025.104465_bib9","unstructured":"Stephen B. Edge, David R. Byrd, Carolyn C. Compton, April G. Fritz, Frederick L. Greene, Andrew Trotti. AJCC cancer staging handbook from the AJCC cancer staging manual."},{"key":"10.1016\/j.breast.2025.104465_bib10","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.1002\/cncr.35323","article-title":"Characterization of HER2\u2010low breast cancer in young women with germline BRCA1\/2 pathogenetic variants: results of a large international retrospective cohort study","volume":"130","author":"Schettini","year":"2024","journal-title":"Cancer."},{"key":"10.1016\/j.breast.2025.104465_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2024.102903","article-title":"Analytical validation of HER2DX genomic test for early-stage HER2-positive breast cancer","volume":"9","author":"Mar\u00edn-Aguilera","year":"2024","journal-title":"ESMO Open"},{"key":"10.1016\/j.breast.2025.104465_bib12","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ctrv.2016.09.004","article-title":"Nab-paclitaxel for the treatment of triple-negative breast cancer: rationale, clinical data and future perspectives","volume":"50","author":"Schettini","year":"2016","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.breast.2025.104465_bib13","article-title":"Extended adjuvant endocrine treatment in luminal breast cancers in the era of genomic tests","volume":"23","author":"Saponaro","year":"2022","journal-title":"International Journal of Molecular Sciences. Multidisciplinary Digital Publishing Institute"},{"key":"10.1016\/j.breast.2025.104465_bib14","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.annonc.2021.06.023","article-title":"Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021","volume":"32","author":"Burstein","year":"2021","journal-title":"Ann Oncol"},{"key":"10.1016\/j.breast.2025.104465_bib15","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1056\/NEJMoa1814017","article-title":"Trastuzumab emtansine for residual invasive HER2-positive breast cancer","volume":"380","author":"Von Minckwitz","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.breast.2025.104465_bib16","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.annonc.2023.11.016","article-title":"Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"35","author":"Loibl","year":"2024","journal-title":"Ann Oncol"},{"key":"10.1016\/j.breast.2025.104465_bib17","first-page":"685","article-title":"Selection of optimal adjuvant chemotherapy and targeted therapy for early breast cancer: ASCO guideline update","volume":"39","author":"Denduluri","year":"2021","journal-title":"J Clin Orthod"},{"key":"10.1016\/j.breast.2025.104465_bib18","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S1470-2045(23)00051-7","article-title":"Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancer: final 10-year analysis of the open-label, single-arm, phase 2 APT trial","volume":"24","author":"Tolaney","year":"2023","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.breast.2025.104465_bib19","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S1470-2045(11)70336-9","article-title":"Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial","volume":"13","author":"Gianni","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.breast.2025.104465_bib20","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0140-6736(13)62422-8","article-title":"Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis","volume":"384","author":"Cortazar","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.breast.2025.104465_bib21","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/s41523-022-00429-7","article-title":"A prospective trial of treatment de-escalation following neoadjuvant paclitaxel\/trastuzumab\/pertuzumab in HER2-positive breast cancer","volume":"8","author":"Waks","year":"2022","journal-title":"NPJ Breast Cancer"},{"key":"10.1016\/j.breast.2025.104465_bib22","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3390\/life14010091","article-title":"An insight into Kounis syndrome: bridging clinical knowledge with forensic perspectives","volume":"14","author":"Forzese","year":"2024","journal-title":"Life"},{"key":"10.1016\/j.breast.2025.104465_bib23","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.clinthera.2013.02.022","article-title":"Coronary hypersensitivity disorder: the Kounis syndrome","volume":"35","author":"Kounis","year":"2013","journal-title":"Clin Ther"},{"key":"10.1016\/j.breast.2025.104465_bib24","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.3390\/jcm13061647","article-title":"Recurrent Kounis syndrome: a case report and literature review","volume":"13","author":"Brancaccio","year":"2024","journal-title":"JCM"},{"issue":"13","key":"10.1016\/j.breast.2025.104465_bib25","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1161\/CIRCULATIONAHA.121.055854","article-title":"Takotsubo syndrome: pathophysiology, emerging concepts, and clinical implications","volume":"145","author":"Singh","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.breast.2025.104465_bib26","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2023.1244808","article-title":"Clinical outcomes of takotsubo syndrome in patients with cancer: a systematic review and meta-analysis","volume":"10","author":"Osawa","year":"2023","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.breast.2025.104465_bib27","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s40521-023-00342-9","article-title":"Drug-Induced Kounis syndrome: latest novelties","volume":"10","author":"Ollo-Morales","year":"2023","journal-title":"Curr Treat Options Allergy"},{"key":"10.1016\/j.breast.2025.104465_bib28","doi-asserted-by":"crossref","first-page":"212","DOI":"10.4274\/balkanmedj.galenos.2019.2019.5.62","article-title":"Kounis syndrome\u2014not a single-organ arterial disorder but a multisystem and multidisciplinary disease","volume":"36","author":"Kounis","year":"2019","journal-title":"Balkan Med J"},{"issue":"6","key":"10.1016\/j.breast.2025.104465_bib29","doi-asserted-by":"crossref","first-page":"E94","DOI":"10.1002\/clc.20291","volume":"32","author":"Gemici","year":"2009","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.breast.2025.104465_bib30","doi-asserted-by":"crossref","first-page":"124","DOI":"10.4070\/kcj.2009.39.3.124","article-title":"Coronary artery thrombosis associated with paclitaxel in advanced ovarian cancer","volume":"39","author":"Park","year":"2009","journal-title":"Korean Circ J."},{"key":"10.1016\/j.breast.2025.104465_bib31","doi-asserted-by":"crossref","first-page":"e62","DOI":"10.1016\/j.ijcard.2009.03.104","article-title":"Kounis syndrome in a patient with ovarian cancer and allergy to iodinated contrast media: report of a case","volume":"149","author":"Oneglia","year":"2011","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.breast.2025.104465_bib32","first-page":"e776","article-title":"Oxaliplatin-Induced coronary vasospasm manifesting as Kounis syndrome: a case report","volume":"29","author":"Chang","year":"2011","journal-title":"J Clin Orthod"},{"key":"10.1016\/j.breast.2025.104465_bib33","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1177\/0267659111410347","article-title":"Is 5-fluorouracil-induced vasospasm a Kounis syndrome? A diagnostic challenge","volume":"26","author":"Karabay","year":"2011","journal-title":"Perfusion"},{"key":"10.1016\/j.breast.2025.104465_bib34","doi-asserted-by":"crossref","first-page":"e58","DOI":"10.1016\/j.jccase.2011.04.004","article-title":"Carboplatin-induced Kounis syndrome","volume":"4","author":"Baroni","year":"2011","journal-title":"Journal of Cardiology Cases"},{"key":"10.1016\/j.breast.2025.104465_bib35","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1177\/1078155214563814","article-title":"Capecitabine-induced ventricular fibrillation arrest: possible Kounis syndrome","volume":"22","author":"Kido","year":"2016","journal-title":"J Oncol Pharm Pract"},{"issue":"3\u20134","key":"10.1016\/j.breast.2025.104465_bib36","first-page":"108","article-title":"Acute myocardial infarction in patient with triple negative breast cancer after paclitaxel infusion: a case report","volume":"5","author":"Esber","year":"2014","journal-title":"Cardiol Res"},{"issue":"10","key":"10.1016\/j.breast.2025.104465_bib37","first-page":"XD01","article-title":"Paclitaxel induced acute st elevation myocardial infarction: a rare case report","volume":"10","author":"Rawal","year":"2016","journal-title":"J Clin Diagn Res"},{"key":"10.1016\/j.breast.2025.104465_bib38","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s12872-021-01936-4","article-title":"Epirubicin-induced Kounis syndrome","volume":"21","author":"Liang","year":"2021","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.breast.2025.104465_bib39","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1111\/imj.15226","article-title":"Type 1 Kounis syndrome after paclitaxel infusion in a patient treated for lung adenocarcinoma","volume":"51","author":"Wang","year":"2021","journal-title":"Intern Med J"},{"issue":"4","key":"10.1016\/j.breast.2025.104465_bib40","doi-asserted-by":"crossref","first-page":"268","DOI":"10.18176\/jiaci.0971","article-title":"Kounis syndrome during an oxaliplatin desensitization protocol","volume":"34","author":"Giangrande","year":"2024","journal-title":"J Investig Allergol Clin Immunol"},{"issue":"1","key":"10.1016\/j.breast.2025.104465_bib41","article-title":"Adrenaline, takotsubo, anaphylaxis, and Kounis syndrome (ATAK) complex unveiled: integrating takotsubo and Kounis syndromes in the context of chemotherapy-related anaphylaxis","volume":"16","author":"Puri","year":"2024","journal-title":"Cureus"},{"key":"10.1016\/j.breast.2025.104465_bib42","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.annonc.2023.05.012","article-title":"Association of HER2DX with pathological complete response and survival outcomes in HER2-positive breast cancer","volume":"34","author":"Villacampa","year":"2023","journal-title":"Ann Oncol"},{"key":"10.1016\/j.breast.2025.104465_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104320","article-title":"HER2DX genomic test in HER2-positive\/hormone receptor-positive breast cancer treated with neoadjuvant trastuzumab and pertuzumab: a correlative analysis from the PerELISA trial","volume":"85","author":"Guarneri","year":"2022","journal-title":"EBioMedicine"},{"key":"10.1016\/j.breast.2025.104465_bib44","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1093\/jnci\/djac227","article-title":"HER2DX ERBB2 mRNA expression in advanced HER2-positive breast cancer treated with T-DM1","volume":"115","author":"Bras\u00f3-Maristany","year":"2023","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.breast.2025.104465_bib45","first-page":"1902","article-title":"ERBB2 mRNA expression and response to ado-trastuzumab emtansine (T-DM1) in HER2-positive breast cancer","volume":"12","author":"Griguolo","year":"2020","journal-title":"Cancers. Multidisciplinary Digital Publishing Institute"},{"key":"10.1016\/j.breast.2025.104465_bib46","unstructured":"REVEAL GENOMICS\u00ae Announces Positive Top-Line Results For HER2DX\u00ae in CLEOPATRA Phase III Trial [Internet]. [cited 2024 Sep 25]. Available from: https:\/\/www.reveal-genomics.com\/press-releases\/reveal-genomics-r-announces-positive-top-line-results-for-her2dx-r-in-cleopatra-phase-iii-trial."},{"key":"10.1016\/j.breast.2025.104465_bib47","doi-asserted-by":"crossref","unstructured":"Walbaum B, Garc\u00eda-Fructuoso I, Mart\u00ednez-S\u00e1ez O, Schettini F, S\u00e1nchez C, F A, et al. Hormone receptor-positive early breast cancer in young women: a comprehensive review. Cancer Treat Rev. 129:102804.","DOI":"10.1016\/j.ctrv.2024.102804"},{"key":"10.1016\/j.breast.2025.104465_bib48","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1056\/NEJMoa1814017","article-title":"Trastuzumab emtansine for residual invasive HER2-positive breast cancer","volume":"380","author":"von Minckwitz","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.breast.2025.104465_bib49","doi-asserted-by":"crossref","unstructured":"Mart\u00ednez-S\u00e1ez O, Cort\u00e9s J, Ciruelos E, Mar\u00edn-Aguilera M, Gonz\u00e1lez G, Par\u00e9 L, et al. Management of early-stage HER2-positive breast cancer and attitudes towards HER2DX test in Spain: insights from a nationwide survey. Clin Transl Oncol. 26:2060\u20132069.","DOI":"10.1007\/s12094-024-03409-4"},{"key":"10.1016\/j.breast.2025.104465_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmorw.2025.100123","article-title":"Clinical decision impact of HER2DX, an algorithm-powered genomic diagnostic in early-stage HER2-positive breast cancer: results from a prospective real-world study","volume":"8","author":"Mart\u00ednez-S\u00e1ez","year":"2025","journal-title":"ESMO Real World Data and Digital Oncology"}],"container-title":["The Breast"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977625004825?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977625004825?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T02:55:11Z","timestamp":1763607311000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960977625004825"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":50,"alternative-id":["S0960977625004825"],"URL":"https:\/\/doi.org\/10.1016\/j.breast.2025.104465","relation":{},"ISSN":["0960-9776"],"issn-type":[{"value":"0960-9776","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Paclitaxel-related type I Kounis Syndrome in a very young patient with HER2-positive breast cancer and the role of genomics to disentangle a complex therapeutic scenario: a case report and narrative review","name":"articletitle","label":"Article Title"},{"value":"The Breast","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.breast.2025.104465","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"104465"}}